首页> 外文期刊>BMC Infectious Diseases >Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018
【24h】

Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 – 2018

机译:描述德国近二十年的Chagas病和学习的经验教训:从2000 - 2018年从筛查,检测,诊断和治疗筛查,检测,诊断和治疗的回顾性研究

获取原文
           

摘要

The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost two decades was collected and analysed. German laboratories offering diagnostics for chronic Trypanosoma cruzi (T. cruzi) infection in routine patient care were identified. All retrievable data on tests performed during the years of 2000–2018 were analysed. Additional clinical information regarding patients diagnosed with CD was collected through questionnaires. Five German laboratories with diagnostics for T. cruzi infection in routine patient care were identified. Centres in Hamburg and Munich offered two independent serological tests to confirm the CD diagnosis, as recommended by WHO during the entire time period 2000–2018. Overall, a total of n?=?10,728 independent tests involving n?=?5991 individuals were identified with a progressive increase in testing rates over time, only n?=?130 (16.0%) of the tested individuals with known nationality came from CD endemic countries. Of all test units conducted at the included institutes, a total of n?=?347/10,728 (3.2%) tests on CD were positive, of which n?=?200/347 (57.6%) were ELISA, n?=?133/347 (38.3%) IFT, n?=?10/347 (2.9%) PCR, and n?=?4/347 (1.2%) RDT. Of the n?=?5991 individuals only n?=?81 (1.4%) with chronic infection were identified, n?=?52 females and n?=?28 males. Additional clinical information could only be collected from n?=?47. The results of this study give insight into the deployment of screening, detection, diagnosis, and treatment of T. cruzi over the last two decades in Germany and existing deficits therein; the creation of guidelines for Germany could be a step forward to improve the existing gaps.
机译:由于拉丁美洲和非流行国家之间的人口流动以及非矢量传输路线,高度复杂和很大程度上被忽视的Chagas疾病(CD)已成为全球卫生问题。收集并分析了德国德国常规患者护理的CD检测和治疗的数据。鉴定了德国实验室为常规患者护理中的慢性锥虫瘤Cruzi(T.Cruzi)感染提供慢性锥虫瘤Cruzi(T.Cruzi)感染。分析了2000-2018年期间进行的测试的所有可检索数据。通过问卷收集有关诊断患有CD的患者的其他临床信息。鉴定了常规患者护理中T.Cruzi感染诊断的五个德国实验室。汉堡和慕尼黑的中心提供了两个独立的血清学检测,以确认CD诊断,根据2000-2018的整个时间段内的世卫组织推荐。总的来说,总共n?=?10,728涉及n?=?5991的独立测试是通过随着时间的推移进行测试率的逐步增加,只有n?=?130(16.0%)具有已知国籍的测试人员来自CD流行国家。在包括在内的机构的所有测试单元中,总共n?= 347 / 10,728(3.2%)对Cd的测试是阳性的,其中N?= 200/347(57.6%)是ELISA,N?=? 133/347(38.3%)IFT,N?= 10/347(2.9%)PCR,N?= 4/347(1.2%)RDT。 n?=?5991只有n?=?81(1.4%)鉴定慢性感染,n?=?52雌性和n?= 28岁。额外的临床信息只能从n?= 47收集。本研究结果介绍了在德国过去二十年中部署T. Cruzi的筛选,检测,诊断和治疗和其中存在的赤字;为德国准则的创建可能是提高现有差距的前进。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号